FBXW4 and colorectal carcinoma: Two independent data sets verified that FBXW4 was the most relevant gene for chemotherapy resistance and was overexpressed in chemotherapy-sensitive CRC patients' tissues compared with chemotherapy-resistant patients' tissues.